close

Enter

Log in using OpenID

Pre-Diabetes/Impaired Glucose Tolerance Market Share, Trends and Regulations, H1, 2016: Hexa Reports

embed
"Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H1, 2016" provides an overview of Pre-Diabetes/Impaired Glucose Tolerance clinical trials scenario.
Hexa Reports
Market Research Reports and Insightful Company Profiles
Pre-Diabetes/Impaired Glucose Tolerance Market Share,
Trends, Size, Growth, Regulations, and Competitive
Landscape, Global Clinical Trials Review, H1, 2016
Summary
GlobalData's clinical trial report, "Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review,
H1, 2016" provides an overview of Pre-Diabetes/Impaired Glucose Tolerance clinical trials scenario. This
report provides top line data relating to the clinical trials on Pre-Diabetes/Impaired Glucose Tolerance.
Report includes an overview of trial numbers and their average enrollment in top countries conducted
across the globe.
The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end
points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on
number of ongoing trials).
Browse Detail Report With TOC @ http://www.hexareports.com/report/pre-diabetes-impairedglucose-tolerance-global-clinical-trials-review-h1-2016/details
GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack
Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences,
journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic
process.
Hexa Reports
Market Research Reports and Insightful Company Profiles
The report enhances the decision making capabilities and helps to create an effective counter strategies
to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance
of data for the indicated disease.
Scope






The report provides a snapshot of the global clinical trials landscape
Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial
Status, Trial Phase, Sponsor Type and End point status
The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status)
pertaining to the company
The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with
reason for unaccomplishment
The Report provides enrollment trends for the past five years
Report provides latest news for the past three months
Request A Sample copy of This Report @ http://www.hexareports.com/sample/121131
Reasons To Buy
1. Assists in formulating key business strategies with regards to investment
2. Helps in identifying prominent locations for conducting clinical trials which saves time and cost
3. Provides top level analysis of Global Clinical Trials Market which helps in identifying key business
opportunities
4. Supports understanding of trials count and enrollment trends by country in global therapeutics
market
5. Aids in interpreting the success rates of clinical trials by providing a comparative scenario of
completed and uncompleted (terminated, suspended or withdrawn) trials
6. Facilitates clinical trial assessment of the indication on a global, regional and country level
Table Of Content






Table of Contents
List of Tables
List of Figures
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Hexa Reports
Market Research Reports and Insightful Company Profiles






Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Pre-Diabetes/Impaired Glucose Tolerance to
Metabolic Disorders Clinical Trials
Browse All Pharmaceuticals & Healthcare Market Research Related Reports @
http://www.hexareports.com/category/pharmaceuticals-and-healthcare-market


























Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Pre-Diabetes/Impaired Glucose Tolerance to
Metabolic Disorders Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical
Trials
Prominent Drugs
Latest Clinical Trials News on Pre-Diabetes/Impaired Glucose Tolerance
Apr 04, 2016: Saxenda demonstrated significant improvements in cardiometabolic risk factors
over three years compared with placebo
Clinical Trial Profile Snapshots
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
Hexa Reports
Market Research Reports and Insightful Company Profiles
Browse Full Report @ http://www.hexareports.com/report/pre-diabetes-impaired-glucose-toleranceglobal-clinical-trials-review-h1-2016/details
About Us:
Hexa Reports is a market research and consulting organization, offering industry reports, custom
research and consulting services to a host of key industries across the globe. We offer comprehensive
business intelligence in the form of industry reports which help our clients obtain clarity about their
business environment and enable them to undertake strategic growth initiatives.
Contact Information:
Ryan Shaw
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number
1-800-489-3075
Email Us: [email protected]
Our Website: http://www.hexareports.com/
Visit our Blog: http://hexareports.blogspot.com/
1/--pages
Report inappropriate content